Skip to content

Home
Team
Contact Us
Visit Global Site

Month: September 2017

AMAL Therapeutics raises €8 million (CHF 8.8 million) in first closing of Series B financing round

Posted on 5th September 201716th November 2017 by helsinn_user

Leave a Comment on AMAL Therapeutics raises €8 million (CHF 8.8 million) in first closing of Series B financing round

Search for:

Recent Posts

Gain Therapeutics, Inc. Announces Close of $10 Million Series B Financing
3B Future Health Fund announces new investment in iOnctura
Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020
Helsinn Investment Fund Announces First Exit

Recent Comments

Archives

July 2020
September 2019
August 2019
July 2019
March 2019
February 2019
April 2018
March 2018
January 2018
November 2017
September 2017
June 2017
May 2017
October 2016
August 2016

Categories

Uncategorised

Meta

Log in
Entries feed
Comments feed
WordPress.org

For further information

pin

Helsinn International Services Sarl
Le Montaigne
7-9 Avenue de Grande Bretagne
MC-98000 Monaco
Principality of Monaco

phone

+377 97 98 30 80

Get in touch

© 2021 Helsinn Group | Terms | Privacy & Cookies Policy | Site by Brandcast

By using Helsinn Investment Fund website you agree to our use of cookies to enhance your experience.